P3 Health Partners Inc (PIII)
0.215
+0.01
(+5.50%)
USD |
NASDAQ |
Nov 21, 16:00
0.2199
0.00 (0.00%)
After-Hours: 20:00
P3 Health Partners Revenue (Quarterly): 362.12M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 362.12M |
| June 30, 2024 | 379.16M |
| March 31, 2024 | 388.49M |
| December 31, 2023 | 346.86M |
| September 30, 2023 | 288.35M |
| June 30, 2023 | 329.09M |
| March 31, 2023 | 302.08M |
| December 31, 2022 | 258.21M |
| Date | Value |
|---|---|
| September 30, 2022 | 248.26M |
| June 30, 2022 | 269.45M |
| March 31, 2022 | 273.54M |
| September 30, 2021 | 156.19M |
| June 30, 2021 | 144.59M |
| March 31, 2021 | 151.30M |
| June 30, 2020 | 116.86M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
116.86M
Minimum
Jun 2020
388.49M
Maximum
Mar 2024
267.64M
Average
273.54M
Median
Mar 2022
Revenue (Quarterly) Benchmarks
| American Shared Hospital Services | 6.999M |
| Omnicell Inc | 282.42M |
| Astrana Health Inc | 478.71M |
| Cryo-Cell International Inc | 8.067M |
| Biote Corp | 51.38M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -46.51M |
| Total Expenses (Quarterly) | 469.11M |
| EPS Diluted (Quarterly) | -0.31 |
| Enterprise Value | 248.89M |
| Profit Margin (Quarterly) | -12.84% |
| Earnings Yield | -400.0% |
| Normalized Earnings Yield | -439.80 |